Vemurafenib in the French temporary authorization for use metastatic melanoma cohort-Reference-Cited by-同舟云学术

Vemurafenib in the French temporary authorization for use metastatic melanoma cohort

Published:2014-02 Issue:1 Volume:24 Page:75-82
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Fennira Feriel,Pagès Cecile,Schneider Pierre,Sidina Irina,Viguier Manuelle,Basset-Seguin Nicole,Madjlessi-Ezra Nika,Madelaine Isabelle,Bagot Martine,Battistella Maxime,Porcher Raphael,Mourah Samia,Lebbé Celeste

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference8 articles.

1. Metastatic melanoma: the new era of targeted therapy.;Guida;Expert Opin Ther Targets,2012

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.;Ferlay;Int J Cancer,2010

3. Melanoma incidence and mortality in Europe: new estimates, persistent disparities.;Forsea;Br J Dermatol,2012

4. Mutations of the BRAF gene in human cancer. (Nature 2002; 417: 949-954).;Millington;Clin Exp Dermatol,2013

5. Role of radiation therapy in cutaneous melanoma.;Hong;Cancer J,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired and intrinsic resistance to vemurafenib in BRAF^V600E‐driven melanoma brain metastases;FEBS Open Bio;2023-11-30

2. BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis;Cancers;2022-12-26

3. Acquired and intrinsic resistance to vemurafenib in BRAF^V600E-driven melanoma brain metastases;2022-12-20

4. Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trial;BMC Cancer;2020-10-09

5. Treatment of Leptomeningeal Metastases;Central Nervous System Metastases;2019-11-06